申请人:Dillon Michael Patrick
公开号:US20100144758A1
公开(公告)日:2010-06-10
The application discloses compounds of the Formula I:
or a pharmaceutically acceptable salt thereof, wherein, X, R
1
, R
2
R
3
, R
4
, R
5
, R
6
, R
7
and R
8
are as defined herein. Also provided are methods of using the compounds for treating diseases associated with the P2X
3
and/or a P2X
2/3
receptor antagonist and methods of making the compounds.
该应用程序披露了Formula I的化合物:
或其药用可接受的盐,其中,X,R
1
,R
2
R
3
,R
4
,R
5
,R
6
,R
7
和R
8
如本文所定义。还提供了使用这些化合物治疗与P2X
3
和/或P2X
2/3
受体拮抗剂相关的疾病的方法以及制备这些化合物的方法。